| Pharmaceutical Economics and Policy | Lifetime | 10 | US 8 | 99.45 |
| Biomedical Ethics and Regulation | Lifetime | 7 | US 5 | 99.05 |
| Pharmaceutical studies and practices | Lifetime | 21 | US 14 | 99.53 |
| Biotechnology and Related Fields | Lifetime | 4 | US 2 | 99.13 |
| Pharmaceutical industry and healthcare | Lifetime | 6 | US 6 | 99.26 |
| Biosimilars and Bioanalytical Methods | Lifetime | 22 | US 6 | 99.20 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 177 | US 86 | 99.40 |
| Economic and Financial Impacts of Cancer | Lifetime | 58 | US 39 | 99.00 |
| Intellectual Property and Patents | Lifetime | 20 | US 14 | 99.04 |
| Health and Medical Research Impacts | Lifetime | 56 | US 31 | 97.89 |
| Medication Adherence and Compliance | Lifetime | 61 | US 44 | 98.63 |
| Medical Malpractice and Liability Issues | Lifetime | 79 | US 49 | 98.27 |
| Healthcare cost, quality, practices | Lifetime | 108 | US 64 | 98.14 |
| Ethics in Clinical Research | Lifetime | 119 | US 70 | 97.20 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 80 | US 28 | 97.01 |
| Statistical Methods in Clinical Trials | Lifetime | 216 | US 115 | 97.02 |
| Science, Research, and Medicine | Lifetime | 49 | US 22 | 95.76 |
| Antibiotic Use and Resistance | Lifetime | 585 | US 200 | 96.62 |
| Pharmaceutical Quality and Counterfeiting | Lifetime | 79 | US 19 | 90.23 |
| Meta-analysis and systematic reviews | Lifetime | 757 | US 237 | 91.90 |
| Innovation Policy and R&D | Lifetime | 880 | US 213 | 85.66 |
| Academic Publishing and Open Access | Lifetime | 204 | US 63 | 79.77 |
| Pharmaceutical Economics and Policy | 2021-2025 | 1 | US 1 | 99.67 |
| Pharmaceutical studies and practices | 2021-2025 | 1 | US 1 | 99.75 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 10 | US 2 | 99.67 |
| Biomedical Ethics and Regulation | 2021-2025 | 1 | US 1 | 99.52 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 4 | US 1 | 99.54 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 10 | US 6 | 99.46 |
| Medication Adherence and Compliance | 2021-2025 | 5 | US 2 | 98.16 |
| Statistical Methods in Clinical Trials | 2021-2025 | 5 | US 3 | 98.80 |
| Pharmaceutical industry and healthcare | 2021-2025 | 1 | US 1 | 99.47 |
| Healthcare cost, quality, practices | 2021-2025 | 45 | US 20 | 95.31 |
| Healthcare Policy and Management | 2021-2025 | 108 | US 87 | 95.52 |
| Biotechnology and Related Fields | 2021-2025 | 6 | US 4 | 94.20 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 112 | US 27 | 93.95 |
| Intellectual Property and Patents | 2021-2025 | 18 | US 6 | 91.59 |
| Ethics in Clinical Research | 2021-2025 | 153 | US 62 | 91.42 |
| Science, Research, and Medicine | 2021-2025 | 98 | US 41 | 62.27 |
| Innovation Policy and R&D | 2021-2025 | 679 | US 75 | 45.01 |
